Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Machine learning-based error detection in the clinical laboratory: a critical review142
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath85
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting69
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease60
Data analytics for error detection in clinical laboratories47
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review43
The anion gap as a predictive tool for morbidity and mortality41
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application39
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications36
Transthyretin mutagenesis: impact on amyloidogenesis and disease35
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology33
Clinical utility of human epididymis protein 432
Evaluating thyroid function in pregnant women28
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation27
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker27
Beyond newborn screening: the role of reverse cascade testing in familial disease detection26
Cardiovascular disease lipids and lipoproteins biomarker standardization26
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration24
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1922
Association of inflammatory biomarkers with morbidity and mortality risk in patients with peripheral artery disease: a systematic review and ­meta-analysis22
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases20
Challenges of insulin-like growth factor-1 testing20
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future18
Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections18
Using a systematic approach to strategic innovation in laboratory medicine to bring about change17
Emerging applications of machine learning in genomic medicine and healthcare17
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?16
The intersection of the laboratory and transgender care15
Revisiting approaches to and considerations for urinalysis and urine culture reflexive testing15
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor14
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders14
Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review14
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review13
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis13
Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review13
Guidelines for diagnosing and differentiating infection with antifungal-resistant Trichophyton indotineae from other dermatophytoses13
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer12
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization12
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?12
From fructose to the future: liver disease biomarkers and their prognostic value in acute liver failure12
Point of care blood glucose devices in the hospital setting12
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)12
DNA/RNA-based electrochemical nanobiosensors for early detection of cancers12
Advances in internal quality control12
0.26258397102356